Overview
With recent CMS reimbursement austerity, some stakeholders believe reductions may continue for 2026, while others expect the pendulum to swing the other way. This critical Deft study will help you prepare for either scenario by offering insights into the MAPD benefits and cost components that seniors value most.
Our research will illuminate major product components — including sensitivity to premium, MOOP, drug deductible, medical deductible, PCP and specialist copays, and more — alongside seniors’ preferences for a litany of supplemental benefits that often drive enrollment.